# Astellas Pharma Inc. – FDA Inspection, Mar 2, 2018

Source: https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/64d4d1f9-e83d-4990-a597-13579281149e
Source feed: FDA_Inspections

> FDA inspection 1042616 of Astellas Pharma Inc., March 02, 2018. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR parts 211 and 820. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1042616
- Company Name: Astellas Pharma Inc.
- Inspection Date: 2018-03-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 3

## Related Documents

- FDA Inspection 1240584 - 2024-04-18
- FDA Inspection 1095974 - 2019-05-31
- [FDA Inspection 995338 - 2016-11-11](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/afba335b-459c-4410-8d03-ca5cc42652ae)
- FDA Inspection 886636 - 2014-06-25
- FDA Inspection 770005 - 2012-02-10

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/saied-a-asbagh/215bfa90-995f-4310-baf3-cd9d37639b7b)

Company: https://www.keypedia.com/companies/astellas-pharma-inc/9a5bc049-426d-4313-b8b8-1ce28d48fa42

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8